Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinberger, M
Right arrow Articles by Tierney, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinberger, M
Right arrow Articles by Tierney, W.
American Journal of Health-System Pharmacy, Vol 58, Issue 9, 791-796
Copyright © 2001 by American Society of Health-System Pharmacists

Articles

Pharmaceutical care program for patients with reactive airways disease

M Weinberger, MD Murray, DG Marrero, N Brewer, M Lykens, LE Harris, and WM Tierney


A pharmaceutical care program for patients with reactive airways disease (RAD) is described. A pharmaceutical care program for patients with RAD was developed and implemented at 36 CVS pharmacies. The impact on patient outcomes, pharmacist job satisfaction, and other variables is currently being evaluated in a controlled trial with more than 1100 patient enrollees. Guiding the program are the beliefs that pharmacists must have clinically relevant, patient-specific data to provide appropriate care; that pharmacists must have adequate training to provide pharmaceutical care; that the program must be sensitive to organizational barriers, particularly time demands; and that there must be ongoing support for the program. The program has five components: (1) computer display of patient-specific data for patients enrolled in the study, (2) distribution of tailored patient education materials, (3) use of a resource guide to facilitate the implementation of pharmaceutical care, (4) strategies to reinforce and facilitate the program, and (5) pharmacist training. While developed for community pharmacies, the program is applicable to most ambulatory care pharmacy practices. A pharmaceutical care program for patients with RAD was developed for use in community pharmacies.
 



This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
M. D. Murray, J. Young, S. Hoke, W. Tu, M. Weiner, D. Morrow, K. T. Stroupe, J. Wu, D. Clark, F. Smith, et al.
Pharmacist Intervention to Improve Medication Adherence in Heart Failure: A Randomized Trial
Ann Intern Med, May 15, 2007; 146(10): 714 - 725.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Med. Inform. Assoc.Home page
M. D. Murray, F. E. Smith, J. Fox, E. Y. Teal, J. G. Kesterson, T. A. Stiffler, R. J. Ambuehl, J. Wang, M. Dibble, D. O. Benge, et al.
Structure, Functions, and Activities of a Research Support Informatics Section
J. Am. Med. Inform. Assoc., July 1, 2003; 10(4): 389 - 398.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. Weinberger, M. D. Murray, D. G. Marrero, N. Brewer, M. Lykens, L. E. Harris, R. Seshadri, H. Caffrey, J. F. Roesner, F. Smith, et al.
Effectiveness of Pharmacist Care for Patients With Reactive Airways Disease: A Randomized Controlled Trial
JAMA, October 2, 2002; 288(13): 1594 - 1602.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society of Health-System Pharmacists.